Hospital

This news highlights the severe business environment faced by so-called "monzen pharmacies" (pharmacies located near medical institutions).The projection of a record number of bankruptcies in FY2025 suggests implications not just for the pharmacy industry but for the entire healthcare delivery system. Specifically, the expansion of dispensing services by drugstores is eroding the revenue base of traditional monzen pharmacies, forcing a reevaluation of collaboration within regional healthcare.

From the perspective of medical M&A and business succession, this situation should be viewed as a "no-time-to-lose" signal.The worsening business conditions of monzen pharmacies are highly likely to be linked to the deteriorating financial health of the medical institutions they are adjacent to. Medical institutions themselves are constantly exposed to risks of financial strain due to a combination of factors, including stagnant medical fee increases, rising labor costs, and the burden of capital investment.

Medical institution executives and monzen pharmacy owners facing issues with management succession should reconsider this news from the viewpoint of "evaluating business succession timing."To avoid the worst-case scenario of bankruptcy and achieve smooth business succession, it is crucial to begin consultations with experts "before" financial conditions worsen. By considering M&A options early, it becomes possible to maximize the transfer price, minimize the impact on staff and patients, and most importantly, chart a course for continued contribution to regional healthcare. Negotiations for the release of personal guarantees are also more likely to proceed favorably when the business is in a sound financial state.